Mycophenolate mofetil vs IV cyclophosphamide
Major infection · patients with induction therapy in lupus nephritis
Mycophenolate mofetil (MMF) showed no clear difference in major infection compared with IV cyclophosphamide (CPA) (low certainty).
1 finding from 1 review
- Immunosuppressive treatment for proliferative lupus nephritis 2018 · Cochrane Headline outcomes onlyRR 1.02 [0.67, 1.54]6 studies · 699 participantsLow